Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

本超级数据集系列（SuperSeries）由下述所列的子数据集系列（SubSeries）组成。整体设计方案：请参阅各独立子系列的相关说明。